These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17162625)

  • 1. Pharmacotherapy for body dysmorphic disorder: treatment received and illness severity.
    Phillips KA; Pagano ME; Menard W
    Ann Clin Psychiatry; 2006; 18(4):251-7. PubMed ID: 17162625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder.
    Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A
    J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive-compulsive disorder versus body dysmorphic disorder: a comparison study of two possibly related disorders.
    Phillips KA; Pinto A; Menard W; Eisen JL; Mancebo M; Rasmussen SA
    Depress Anxiety; 2007; 24(6):399-409. PubMed ID: 17041935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight in obsessive compulsive disorder and body dysmorphic disorder.
    Eisen JL; Phillips KA; Coles ME; Rasmussen SA
    Compr Psychiatry; 2004; 45(1):10-5. PubMed ID: 14671731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.
    Phillips KA; McElroy SL; Dwight MM; Eisen JL; Rasmussen SA
    J Clin Psychiatry; 2001 Feb; 62(2):87-91. PubMed ID: 11247107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body dysmorphic disorder.
    Allen A; Hollander E
    Psychiatr Clin North Am; 2000 Sep; 23(3):617-28. PubMed ID: 10986731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body dysmorphic disorder: diagnostic controversies and treatment challenges.
    Phillips KA
    Bull Menninger Clin; 2000; 64(1):18-35. PubMed ID: 10695157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach.
    Phillips KA; Hollander E
    Body Image; 2008 Mar; 5(1):13-27. PubMed ID: 18325859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
    Phillips KA; Albertini RS; Siniscalchi JM; Khan A; Robinson M
    J Clin Psychiatry; 2001 Sep; 62(9):721-7. PubMed ID: 11681769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fluvoxamine in body dysmorphic disorder.
    Phillips KA; Dwight MM; McElroy SL
    J Clin Psychiatry; 1998 Apr; 59(4):165-71. PubMed ID: 9590666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of body dysmorphic disorder in adolescents.
    Hadley SJ; Greenberg J; Hollander E
    Curr Psychiatry Rep; 2002 Apr; 4(2):108-13. PubMed ID: 11914171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current concepts in body dysmorphic disorder.
    Carroll DH; Scahill L; Phillips KA
    Arch Psychiatr Nurs; 2002 Apr; 16(2):72-9. PubMed ID: 11925574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive disorder and body dysmorphic disorder: a comparison of clinical features.
    Frare F; Perugi G; Ruffolo G; Toni C
    Eur Psychiatry; 2004 Aug; 19(5):292-8. PubMed ID: 15276662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
    Nakamae T
    Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognizing and treating body dysmorphic disorder.
    Grant JE; Phillips KA
    Ann Clin Psychiatry; 2005; 17(4):205-10. PubMed ID: 16402752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body dysmorphic disorder: treating an underrecognized disorder.
    Phillips KA; Didie ER; Feusner J; Wilhelm S
    Am J Psychiatry; 2008 Sep; 165(9):1111-8. PubMed ID: 18765493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.
    Phillips KA; Stout RL
    J Psychiatr Res; 2006 Jun; 40(4):360-9. PubMed ID: 16309706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity of body dysmorphic disorder and eating disorders: severity of psychopathology and body image disturbance.
    Ruffolo JS; Phillips KA; Menard W; Fay C; Weisberg RB
    Int J Eat Disord; 2006 Jan; 39(1):11-9. PubMed ID: 16254870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.
    Phillips KA; Albertini RS; Rasmussen SA
    Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.